Freezing device for skin tags: test of a new pen
Part of Skin clinical trials.
This trial tests a new cryogenic pen that freezes off skin tags to see if it works better than an existing device. It may be an option if you have small, soft, skin-colored skin tags in certain body areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in good general health.
- You are at least 22 years old.
- You have skin tags on your neck, chest, back, groin, or underarm that are 2 to 5 mm small, soft, and the same color as your skin.
- You are not pregnant, nursing, or planning pregnancy, and if you can get pregnant you use birth control.
- You do not have skin diseases, cancer, or healing problems like keloids, and are not taking certain medications like steroids or blood thinners.
- You agree to follow the study rules and have health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether freezing treatment done through the skin (cryotherapy) can reduce pain and discomfort from certain non-cancer NF1 tumors that can’t be safely removed. You may be able to join if you’re an adult with NF1, a painful or bothersome benign lesion, and can safely undergo procedures like MRI.
This trial uses a very thin freezing needle to take a sample (biopsy) and then freeze and destroy lung nodules that may be cancer. It is for people whose nodules are small and who cannot or choose not to have surgery or radiation.
This trial tests a special marker that numbs the skin before medical procedures. It may help reduce pain during injections or minor skin treatments.
This trial tests cryoablation (freezing the tumor with a needle) as a way to treat small, low-risk breast cancers without surgery. It is for women 50 or older whose cancers are hormone-receptor-positive and haven't spread to lymph nodes.
This study tests a new medicine called SPOT-mRNA01, given as a small injection under the skin, to see if it is safe and well-tolerated. It is an early-stage trial in healthy volunteers, which means it is not yet testing whether the medicine works for a disease.
This study tests a radiofrequency device to tighten facial skin temporarily. It may be a treatment option for people who want non-surgical skin tightening.
Hear when a new Skin Tags trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.